Laparoscopic cytoreduction after neoadjuvant chemotherapy (LANCE): feasibility phase of a randomized trial

被引：0

作者：

Rauh-Hain, J. Alejandro ^{[1
]}

Melamed, Alexander ^{[2
]}

Pareja, Rene ^{[3
]}

Sinno, Abdulrahman ^{[4
]}

Mcnally, Leah ^{[5
]}

Horowitz, Neil ^{[6
]}

Iaco, Pierandrea De ^{[7
]}

Michener, Chad ^{[8
]}

May, Taymaa ^{[9
]}

Lonkhuijzen, Luc Van ^{[10
]}

Iniesta, Maria ^{[1
]}

Suki, Tina ^{[1
]}

Yuan, Ying ^{[1
]}

Coleman, Robert ^{[11
]}

Ramirez, Pedro ^{[12
]}

Fagotti, Anna ^{[13
]}

机构：

[1] MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med, Houston, TX USA

[2] Massachusetts Gen Hosp, Obstet & Gynecol, Boston, MA USA

[3] Hosp Gen Medellin, Gynecol Oncol, Medellin, Colombia

[4] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Obstet & Gynecol, Miami, FL USA

[5] Duke Univ, Obstet & Gynecol, Durham, NC USA

[6] Dana Farber Canc Ctr, Gynecol Oncol, Boston, MA USA

[7] Univ Bologna, Obstet & Gynecol, Bologna, Italy

[8] Cleveland Clin, Dept Obstet & Gynecol, Cleveland, OH USA

[9] Princess Margaret Canc Ctr, Gynecol Oncol, Toronto, ON, Canada

[10] Univ Amsterdam, Med Ctr, Gynecol Oncol, Amsterdam, Netherlands

[11] US Oncol, Texas Oncol, Houston, TX USA

[12] Methodist Hosp, Obstet & Gynecol, Houston, TX USA

[13] Fdn Policlin A Gemelli, Gynecol Oncol, Rome, Italy

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期

关键词：

D O I：

10.1136/ijgc-2023-IGCS.14

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO014

引用

页码：A12 / A12

页数：1

共 50 条

[41] Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Yao, Shih-Ern
Tripcony, Lee
Sanday, Karen
Robertson, Jessica
Perrin, Lewis
Chetty, Naven
Land, Russell
Garrett, Andrea
Obermair, Andreas
Nascimento, Marcelo
Tang, Amy
Jagasia, Nisha
Singh, Piksi
Nicklin, Jim
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (12) : 1935 - 1942
[42] A-BRAVE trial: A phase III randomized trial with avelumab in early triple-negative breast cancer with residual disease after neoadjuvant chemotherapy or at high risk after primary surgery and adjuvant chemotherapy.
Conte, Pier Franco
Dieci, Maria Vittoria
Bisagni, Giancarlo
Schmid, Peter
Fotia, Vittoria
Piacentini, Federico
De Laurentiis, Michelino
Favaretto, Adolfo G.
Tamberi, Stefano
Bianchi, Giulia Valeria
Zamagni, Claudio
Cinieri, Saverio
Corsi, Domenico C.
Del Mastro, Lucia
Ferro, Antonella
Gennari, Alessandra
Mion, Marta
Musolino, Antonino
De Salvo, Gian Luca
Guarneri, Valentina
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA500 - LBA500
[43] Neoadjuvant chemotherapy in cervical carcinoma stage IIB:: a randomized controlled trial
Sardi, JE
Sananes, CE
Giaroli, AA
Bermúdez, A
Ferreira, MH
Soderini, AH
Snaidas, L
Guardado, N
Anchezar, P
Ortiz, OC
Di Paola, GR
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1998, 8 (06) : 441 - 450
[44] A PHASE-II TRIAL INVESTIGATING PRIMARY IMMUNOCHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA AND THE FEASIBILITY OF ADJUVANT IMMUNOCHEMOTHERAPY AFTER MAXIMAL CYTOREDUCTION
PASS, HW
TEMECK, BK
KRANDA, K
STEINBERG, SM
PASS, HI
ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (03) : 214 - 220
[45] Safety and feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy for esophageal cancer
Fujiwara, Yushi
Lee, Shigeru
Kishida, Satoru
Hashiba, Ryoya
Gyobu, Ken
Takemura, Masashi
Osugi, Harushi
SURGERY TODAY, 2017, 47 (11) : 1356 - 1360
[46] Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial
de Arruda, Fernanda Nunes
da Costa, Samantha
Bonadio, Renata
Dornellas, Abraao
Pereira, Daniela
de Bock, Geertruida H.
Estevez Diz, Maria Del Pilar
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (06) : 749 - 756
[47] FEASIBILITY AND EFFICACY OF NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCER: A RANDOMISED TRIAL
Ahmed, Banday Manzoor
Wani, Khursheed Alam
Wani, Majid
EUROPEAN JOURNAL OF CANCER, 2015, 51 : E1 - E2
[48] Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial
Nasrolahi, Hamid
Mirzaei, Sepideh
Mohammadianpanah, Mohammad
Bananzadeh, Ali Mohammad
Mokhtari, Maral
Sasani, Mohammad Reza
Mosalaei, Ahmad
Omidvari, Shapour
Ansari, Mansour
Ahmadloo, Niloofar
Hamedi, Seyed Hasan
Khanjani, Nezhat
ANNALS OF COLOPROCTOLOGY, 2019, 35 (05) : 242 - 248
[49] Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial
Stefanie de Groot
Rieneke T. Lugtenberg
Danielle Cohen
Marij J. P. Welters
Ilina Ehsan
Maaike P. G. Vreeswijk
Vincent T. H. B. M. Smit
Hiltje de Graaf
Joan B. Heijns
Johanneke E. A. Portielje
Agnes J. van de Wouw
Alex L. T. Imholz
Lonneke W. Kessels
Suzan Vrijaldenhoven
Arnold Baars
Elma Meershoek-Klein Kranenbarg
Marjolijn Duijm-de Carpentier
Hein Putter
Jacobus J. M. van der Hoeven
Johan W. R. Nortier
Valter D. Longo
Hanno Pijl
Judith R. Kroep
Nature Communications, 11
[50] Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial
Loi, Sherene
Salgado, Roberto
Curigliano, Giuseppe
Romero Diaz, Roberto Ivan
Delaloge, Suzette
Rojas Garcia, Carlos Ignacio
Kok, Marleen
Saura, Cristina
Harbeck, Nadia
Mittendorf, Elizabeth A.
Yardley, Denise A.
Suarez Zaizar, Alberto
Caminos, Facundo Rufino
Ungureanu, Andrei
Reinoso-Toledo, Joaquin G.
Guarneri, Valentina
Egle, Daniel
Ades, Felipe
Pacius, Misena
Chhibber, Aparna
Chandra, Rajalakshmi
Nathani, Raheel
Spires, Thomas
Wu, Jenny Qun
Pusztai, Lajos
Mcarthur, Heather
NATURE MEDICINE, 2025, 31 (02) : 433 - 441

← 1 2 3 4 5 →